By NewsDesk  @infectiousdiseasenews On Wednesday, the National Institutes of Health (NIH) reported that preliminary data analysis from a clinical trial on the investigational antiviral drug, remdesivir,...

UC San Diego Health has launched a Phase III clinical trial, part of a global effort, to assess whether a medication used to treat rheumatoid arthritis and other inflammatory disorders might also have...

On Friday, the US Food and Drug Administration (FDA) issued a safety alert concerning the use of hydroxychloroquine or chloroquine for the treatment of COVID-19. FDA is concerned that hydroxychloroquine...

SCYNEXIS, Inc. announced this week positive top-line results for its Phase 3 VANISH-306 study investigating the safety and efficacy of oral ibrexafungerp, a novel broad-spectrum antifungal, as a treatment...

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for...

Nearly two thirds of severely ill patients hospitalized with COVID-19 who received remdesivir on a compassionate-use basis improved, with no new concerns about safety reported during the short clinical...

Kenji Sukeno, the President of FUJIFILM Corporation announced Wednesday that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its...

Temple University Hospital has treated the first patient in the United States in the BREATHE clinical trial evaluating the impact of intravenous treatment with gimsilumab on mortality for patients with...

Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research...

Eli Lilly and Company announced Friday it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to...